ATE325131T1 - Neues protein und verfahren zu dessen herstellung - Google Patents
Neues protein und verfahren zu dessen herstellungInfo
- Publication number
- ATE325131T1 ATE325131T1 AT96910198T AT96910198T ATE325131T1 AT E325131 T1 ATE325131 T1 AT E325131T1 AT 96910198 T AT96910198 T AT 96910198T AT 96910198 T AT96910198 T AT 96910198T AT E325131 T1 ATE325131 T1 AT E325131T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- seq
- purifying
- amino acid
- acid sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9366495 | 1995-04-19 | ||
JP32240395 | 1995-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE325131T1 true ATE325131T1 (de) | 2006-06-15 |
Family
ID=26434967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96910198T ATE325131T1 (de) | 1995-04-19 | 1996-04-19 | Neues protein und verfahren zu dessen herstellung |
Country Status (18)
Country | Link |
---|---|
US (3) | US7235527B2 (de) |
EP (1) | EP0955313B1 (de) |
AT (1) | ATE325131T1 (de) |
AU (1) | AU704515C (de) |
BR (1) | BR9608019A (de) |
CA (1) | CA2216741C (de) |
DE (2) | DE69636728T4 (de) |
DK (1) | DK0955313T3 (de) |
EA (1) | EA000582B1 (de) |
ES (1) | ES2258774T3 (de) |
HU (1) | HU225424B1 (de) |
NO (1) | NO321153B1 (de) |
NZ (1) | NZ305472A (de) |
OA (1) | OA10528A (de) |
PL (1) | PL186518B1 (de) |
PT (1) | PT955313E (de) |
UA (1) | UA46767C2 (de) |
WO (1) | WO1996033215A1 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6586388B2 (en) | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
US20070166353A1 (en) * | 1988-04-08 | 2007-07-19 | Stryker Corporation | Osteogenic proteins |
US20080233170A1 (en) * | 1992-02-21 | 2008-09-25 | Stryker Corporation | Osteogenic Proteins |
ZA9711580B (en) * | 1996-12-25 | 1999-09-23 | Hoechst Marion Roussel Ltd | Process for the production of purified dimeric bone morphogenetic factors. |
EP0972520B9 (de) * | 1997-01-30 | 2006-03-22 | Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH | Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52 |
DE69814352T3 (de) † | 1997-02-07 | 2009-08-13 | Stryker Corp., Kalamazoo | Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung |
US6727224B1 (en) | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
WO2006104306A1 (en) * | 2005-03-30 | 2006-10-05 | Jung Moon Kim | Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
KR100775958B1 (ko) | 2005-03-30 | 2007-11-13 | 김정문 | 조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법 |
US20060286144A1 (en) * | 2005-06-17 | 2006-12-21 | Chunlin Yang | Reinforced collagen scaffold |
PL1948689T3 (pl) | 2005-11-18 | 2012-09-28 | Biopharm Ges Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Mutanty czynników wzrostu o wysokiej aktywności |
EP1880731A1 (de) * | 2006-07-18 | 2008-01-23 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Menschlicher Wachstums und Differenzierungsfaktor GDF-5 |
AU2007234612B2 (en) * | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
PT2121142E (pt) * | 2007-01-25 | 2013-04-30 | Bioph Biotech Entw Pharm Gmbh | Utilização de gdf-5 para a melhoria ou conservação do aspeto dérmico |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
EP2019117A1 (de) * | 2007-07-27 | 2009-01-28 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Optimiertes Reinigungsverfahren für rekombinantes Wachstumsfaktorprotein |
WO2009020744A1 (en) | 2007-08-07 | 2009-02-12 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations comprising gdf-5 in aqueous acidic solution |
JP2009106163A (ja) * | 2007-10-26 | 2009-05-21 | Kyushu Univ | 核酸配列、ベクター、形質転換体、製造方法、及び、核酸配列プライマー |
AU2009236459B2 (en) * | 2008-04-14 | 2013-07-25 | Advanced Technologies And Regenerative Medicine, Llc | Liquid buffered GDF-5 formulations |
US9226898B1 (en) * | 2009-11-18 | 2016-01-05 | Richard C. K. Yen | Submicron particles for the treatment of radiation damage in patients |
US11260110B2 (en) | 2009-11-18 | 2022-03-01 | Ptlnv, Llc, Series Four (4) | Nanoparticles for the therapeutic treatment of radiation-induced skin ulcers |
WO2012013790A1 (en) | 2010-07-30 | 2012-02-02 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Drug delivery devices and growth factor formulations for accelerated wound healing |
US8551525B2 (en) | 2010-12-23 | 2013-10-08 | Biostructures, Llc | Bone graft materials and methods |
US8398611B2 (en) | 2010-12-28 | 2013-03-19 | Depuy Mitek, Inc. | Compositions and methods for treating joints |
US8455436B2 (en) | 2010-12-28 | 2013-06-04 | Depuy Mitek, Llc | Compositions and methods for treating joints |
US8524662B2 (en) | 2010-12-28 | 2013-09-03 | Depuy Mitek, Llc | Compositions and methods for treating joints |
EP2537538A1 (de) | 2011-06-22 | 2012-12-26 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | Bioresorbierbarer Wundverband |
US8623839B2 (en) | 2011-06-30 | 2014-01-07 | Depuy Mitek, Llc | Compositions and methods for stabilized polysaccharide formulations |
EP2602264A1 (de) | 2011-12-05 | 2013-06-12 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | GDF-5-Mutant zur Induzierung der Knorpelbildung |
US9682099B2 (en) | 2015-01-20 | 2017-06-20 | DePuy Synthes Products, Inc. | Compositions and methods for treating joints |
US20220387556A1 (en) | 2019-12-18 | 2022-12-08 | Merck Patent Gmbh | Use of the gdf-5 mutant for the treatment of pain and cartilage destruction |
KR20240064367A (ko) * | 2022-11-04 | 2024-05-13 | 주식회사 대웅제약 | TGF-β3 단백질의 정제방법 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4725234A (en) * | 1985-08-15 | 1988-02-16 | Ethridge Edwin C | Alveolar bone grafting process with controlled surface active ceramics |
US5079352A (en) * | 1986-08-22 | 1992-01-07 | Cetus Corporation | Purified thermostable enzyme |
US5354557A (en) * | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
US5143829A (en) * | 1990-03-29 | 1992-09-01 | California Biotechnology Inc. | High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
US5118667A (en) * | 1991-05-03 | 1992-06-02 | Celtrix Pharmaceuticals, Inc. | Bone growth factors and inhibitors of bone resorption for promoting bone formation |
US5171579A (en) * | 1991-10-11 | 1992-12-15 | Genetics Institute, Inc. | Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
JP3504263B2 (ja) | 1991-11-04 | 2004-03-08 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | 組み換え型骨形態形成蛋白ヘテロダイマー、組成物および使用法 |
PT625989E (pt) * | 1992-02-12 | 2000-06-30 | Bioph Biotech Entw Pharm Gmbh | Sequencias de adn que codificam novos factores de crescimento/diferenciacao |
JP3645258B2 (ja) | 1993-01-12 | 2005-05-11 | ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン | 増殖分化因子−5 |
IL110589A0 (en) | 1993-08-10 | 1994-11-11 | Bioph Biotech Entw Pharm Gmbh | Growth/differentiation factor of the TGF- beta family |
US6248554B1 (en) | 1993-11-24 | 2001-06-19 | The Procter & Gamble Company | DNA sequence coding for a BMP receptor |
DE69434651T2 (de) * | 1993-12-07 | 2007-03-08 | Genetics Institute, Inc., Cambridge | Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen |
US5399677A (en) | 1993-12-07 | 1995-03-21 | Genetics Institute, Inc. | Mutants of bone morphogenetic proteins |
US5707962A (en) * | 1994-09-28 | 1998-01-13 | Gensci Regeneration Sciences Inc. | Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof |
-
1996
- 1996-04-19 EP EP96910198A patent/EP0955313B1/de not_active Expired - Lifetime
- 1996-04-19 NZ NZ305472A patent/NZ305472A/en not_active IP Right Cessation
- 1996-04-19 DE DE69636728T patent/DE69636728T4/de not_active Expired - Lifetime
- 1996-04-19 CA CA002216741A patent/CA2216741C/en not_active Expired - Fee Related
- 1996-04-19 AU AU53470/96A patent/AU704515C/en not_active Ceased
- 1996-04-19 PT PT96910198T patent/PT955313E/pt unknown
- 1996-04-19 US US08/945,459 patent/US7235527B2/en not_active Expired - Fee Related
- 1996-04-19 DK DK96910198T patent/DK0955313T3/da active
- 1996-04-19 ES ES96910198T patent/ES2258774T3/es not_active Expired - Lifetime
- 1996-04-19 UA UA97115563A patent/UA46767C2/uk unknown
- 1996-04-19 WO PCT/JP1996/001062 patent/WO1996033215A1/ja active IP Right Grant
- 1996-04-19 EA EA199700329A patent/EA000582B1/ru not_active IP Right Cessation
- 1996-04-19 AT AT96910198T patent/ATE325131T1/de active
- 1996-04-19 PL PL96322945A patent/PL186518B1/pl not_active IP Right Cessation
- 1996-04-19 BR BR9608019-1A patent/BR9608019A/pt not_active IP Right Cessation
- 1996-04-19 HU HU9801697A patent/HU225424B1/hu not_active IP Right Cessation
- 1996-04-19 DE DE69636728A patent/DE69636728D1/de not_active Expired - Lifetime
-
1997
- 1997-10-17 OA OA70112A patent/OA10528A/en unknown
- 1997-10-17 NO NO19974812A patent/NO321153B1/no not_active IP Right Cessation
-
2003
- 2003-02-12 US US10/365,231 patent/US7268114B2/en not_active Expired - Fee Related
-
2007
- 2007-08-03 US US11/833,653 patent/US7816103B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69636728D1 (de) | Neues protein und verfahren zu dessen herstellung | |
JP3762222B2 (ja) | 改変型TGF−βスーパーファミリータンパク質 | |
AU656354B2 (en) | Synthetic bioadhesive polypeptide | |
WO1995021919A3 (en) | Protein having tpo activity | |
BG100236A (en) | Sheared keratiocytic growth factor (kgf) of increased biological activity | |
NO20065528L (no) | Forbindelser som fremmer vevsvekst. | |
DE3587422D1 (de) | Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins. | |
DE69028499T2 (de) | Neues Verfahren zur Produktion von nichtfusioniertem Protein in E. coli | |
DE69012377D1 (de) | Polypeptid und dessen Herstellung. | |
DE69530647D1 (de) | Für biosynthetische Insulinvorstufen kodierende DNA-Sequenzen und Verfahren zur Herstellung von Insulin | |
CA2227204A1 (en) | Human mp52 arg protein | |
EP0453456B1 (de) | Pdgf-a, pdgf-aa, pdgf-ab, herstellungsverfahren und sie enthaltende arzneimittel | |
DE3767629D1 (de) | Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung. | |
Purchio et al. | Synthesis of an active hybrid growth factor (GF) in bacteria: transforming GF-α/vaccinia GF fusion protein | |
MX9504057A (es) | Proteina que tiene actividad tpo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0955313 Country of ref document: EP |